DCAT Value Chain Insights

FDA Outlines New Pathway for Competitive Generic Therapies

As part of its Drug Competition Action Plan, the US Food and Drug Administration (FDA) has issued draft guidance to outline a new regulatory pathway for “competitive generic therapies” (CGTs) to...

DCAT Week ’19 Preview: Global Pharma Industry Outlook, Executive Insights and Nobel Laureate in Chemistry

How did the pharma industry perform in 2018, and what is the outlook for 2019 and beyond? What are the key drivers shaping drug-development and commercialization, and what is the impact on...

Cambrex eBook - Small molecules 2.0: the bigger picture

Information
February 20, 2019
Sponsored by Cambrex

The Cambrex eBook contains 30 more thought leading articles from the world's fastest growing small molecule company. Discover the highest number of NCEs approved by the FDA.

Read More
Continuous Flow for APIs and Intermediates (Part 2)

Information
February 13, 2019
Sponsored by Cambrex

Cambrex’s Dr. Shawn Conway, Director of Engineering, R&D, outlines how continuous flow processes simplify and break through traditional method limitations to achieve efficiencies in cost, quality and...

Read More
Continuous Flow for APIs & Intermediates (Part 1)

Information
February 6, 2019
Sponsored by Cambrex

After a brief history of the continuous flow process, Cambrex’s Jonathan Knight and Fredrik Stenberg discuss its benefits over traditional batch operations – including cost, quality and safety.

Read More